Clinical programs

CLINICAL DEVELOPMENT PROGRAMS

Building on its long tradition of scientific excellence, Transgene is focused on discovering and developing a broad pipeline of innovative immunotherapies in the areas of cancer and infectious diseases. This pipeline is being fed by Transgene’s internal research efforts focused on its core viral vector technology, complemented by in-licensing activities. The company currently has four programs in clinical development plus several programs in research and pre-clinical.

 

A list of select publications related to our clinical programs can be found in the R&D section of our website.

 

 

Cancers


TG4010

Pexa-Vec (JX594/TG6006)

Infectious diseases


TG4040

TG4001